These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 32067626)
1. Optimizing the Number of Child Deaths Averted with Mass Azithromycin Distribution. Oldenburg CE; Arzika AM; Maliki R; Lin Y; O'Brien KS; Keenan JD; Lietman TM; For The Mordor Study Group Am J Trop Med Hyg; 2020 Sep; 103(3):1308-1310. PubMed ID: 32067626 [TBL] [Abstract][Full Text] [Related]
2. Cost-Effectiveness of Mass Treatment with Azithromycin for Reducing Child Mortality in Malawi: Secondary Analysis from the MORDOR Trial. Hart JD; Kalua K; Keenan JD; Lietman TM; Bailey RL Am J Trop Med Hyg; 2020 Sep; 103(3):1283-1290. PubMed ID: 32342840 [TBL] [Abstract][Full Text] [Related]
3. Biannual Treatment of Preschool Children with Single Dose Azithromycin to Reduce Mortality: Impact on Azithromycin Resistance in the MORDOR Trial in Tanzania. Bloch EM; Coles CL; Kasubi M; Weaver J; Mrango Z; Munoz B; Lietman TM; West SK Am J Trop Med Hyg; 2020 Sep; 103(3):1301-1307. PubMed ID: 32067633 [TBL] [Abstract][Full Text] [Related]
4. Effect of Mass Treatment with Azithromycin on Causes of Death in Children in Malawi: Secondary Analysis from the MORDOR Trial. Hart JD; Kalua K; Keenan JD; Lietman TM; Bailey RL Am J Trop Med Hyg; 2020 Sep; 103(3):1319-1328. PubMed ID: 32342837 [TBL] [Abstract][Full Text] [Related]
5. Cause-specific mortality of children younger than 5 years in communities receiving biannual mass azithromycin treatment in Niger: verbal autopsy results from a cluster-randomised controlled trial. Keenan JD; Arzika AM; Maliki R; Elh Adamou S; Ibrahim F; Kiemago M; Galo NF; Lebas E; Cook C; Vanderschelden B; Bailey RL; West SK; Porco TC; Lietman TM; Lancet Glob Health; 2020 Feb; 8(2):e288-e295. PubMed ID: 31981558 [TBL] [Abstract][Full Text] [Related]
6. Prolonged mass azithromycin distributions and macrolide resistance determinants among preschool children in Niger: A sub-study of a cluster-randomized trial (MORDOR). Arzika AM; Abdou A; Maliki R; Beido N; Kadri B; Harouna AN; Galo AN; Alio MK; Lebas E; Oldenburg CE; O'Brien KS; Chen C; Zhong L; Zhou Z; Yan D; Hinterwirth A; Keenan JD; Porco TC; Lietman TM; Doan T; PLoS Med; 2024 May; 21(5):e1004386. PubMed ID: 38709718 [TBL] [Abstract][Full Text] [Related]
7. Effect Modification by Baseline Mortality in the MORDOR Azithromycin Trial. Oron AP; Burstein R; Mercer LD; Arzika AM; Kalua K; Mrango Z; West SK; Bailey RL; Porco TC; Lietman TM Am J Trop Med Hyg; 2020 Sep; 103(3):1295-1300. PubMed ID: 30734696 [TBL] [Abstract][Full Text] [Related]
8. Longer-Term Assessment of Azithromycin for Reducing Childhood Mortality in Africa. Keenan JD; Arzika AM; Maliki R; Boubacar N; Elh Adamou S; Moussa Ali M; Cook C; Lebas E; Lin Y; Ray KJ; O'Brien KS; Doan T; Oldenburg CE; Callahan EK; Emerson PM; Porco TC; Lietman TM N Engl J Med; 2019 Jun; 380(23):2207-2214. PubMed ID: 31167050 [TBL] [Abstract][Full Text] [Related]
9. Effects of Biannual Azithromycin Mass Drug Administration on Malaria in Malawian Children: A Cluster-Randomized Trial. Hart JD; Samikwa L; Sikina F; Kalua K; Keenan JD; Lietman TM; Burr SE; Bailey RL Am J Trop Med Hyg; 2020 Sep; 103(3):1329-1334. PubMed ID: 32342841 [TBL] [Abstract][Full Text] [Related]
10. Distance to Health Centers and Effectiveness of Azithromycin Mass Administration for Children in Niger: A Secondary Analysis of the MORDOR Cluster Randomized Trial. Chao DL; Arzika AM; Abdou A; Maliki R; Karamba A; Galo N; Beidi D; Harouna N; Abarchi M; Root E; Mishra A; Lebas E; Arnold BF; Oldenburg CE; Keenan JD; Lietman TM; O'Brien KS JAMA Netw Open; 2023 Dec; 6(12):e2346840. PubMed ID: 38100110 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of Mass Azithromycin Distribution for Reducing Childhood Mortality Across Geographic Regions. Porco TC; Oldenburg CE; Arzika AM; Kalua K; Mrango Z; Cook C; Lebas E; Bailey RL; West SK; Oron AP; Keenan JD; Lietman TM; For The Mordor Study Group Am J Trop Med Hyg; 2020 Sep; 103(3):1291-1294. PubMed ID: 30734695 [TBL] [Abstract][Full Text] [Related]
12. Biannual azithromycin distribution and child mortality among malnourished children: A subgroup analysis of the MORDOR cluster-randomized trial in Niger. O'Brien KS; Arzika AM; Maliki R; Manzo F; Mamkara AK; Lebas E; Cook C; Bailey RL; West SK; Oldenburg CE; Porco TC; Arnold B; Keenan JD; Lietman TM; PLoS Med; 2020 Sep; 17(9):e1003285. PubMed ID: 32931496 [TBL] [Abstract][Full Text] [Related]
13. Macrolide and Nonmacrolide Resistance with Mass Azithromycin Distribution. Doan T; Worden L; Hinterwirth A; Arzika AM; Maliki R; Abdou A; Zhong L; Chen C; Cook C; Lebas E; O'Brien KS; Oldenburg CE; Chow ED; Porco TC; Lipsitch M; Keenan JD; Lietman TM N Engl J Med; 2020 Nov; 383(20):1941-1950. PubMed ID: 33176084 [TBL] [Abstract][Full Text] [Related]
14. Childhood Mortality After Mass Distribution of Azithromycin: A Secondary Analysis of the PRET Cluster-randomized Trial in Niger. O'Brien KS; Cotter SY; Amza A; Kadri B; Nassirou B; Stoller NE; Zhou Z; West SK; Bailey RL; Keenan JD; Porco TC; Lietman TM Pediatr Infect Dis J; 2018 Nov; 37(11):1082-1086. PubMed ID: 29561511 [TBL] [Abstract][Full Text] [Related]
15. Azithromycin to prevent deaths in children. The Lancet Infectious Diseases Lancet Infect Dis; 2018 Jun; 18(6):583. PubMed ID: 29856346 [No Abstract] [Full Text] [Related]